KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Retained Earnings (2018 - 2025)

Historic Retained Earnings for Adaptive Biotechnologies (ADPT) over the last 8 years, with Q3 2025 value amounting to -$1.3 billion.

  • Adaptive Biotechnologies' Retained Earnings fell 626.8% to -$1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 billion, marking a year-over-year decrease of 626.8%. This contributed to the annual value of -$1.3 billion for FY2024, which is 1393.76% down from last year.
  • According to the latest figures from Q3 2025, Adaptive Biotechnologies' Retained Earnings is -$1.3 billion, which was down 626.8% from -$1.4 billion recorded in Q2 2025.
  • Over the past 5 years, Adaptive Biotechnologies' Retained Earnings peaked at -$552.3 million during Q1 2021, and registered a low of -$1.4 billion during Q2 2025.
  • In the last 5 years, Adaptive Biotechnologies' Retained Earnings had a median value of -$1.0 billion in 2023 and averaged -$1.0 billion.
  • In the last 5 years, Adaptive Biotechnologies' Retained Earnings plummeted by 4153.4% in 2022 and then tumbled by 626.8% in 2025.
  • Over the past 5 years, Adaptive Biotechnologies' Retained Earnings (Quarter) stood at -$718.9 million in 2021, then dropped by 27.85% to -$919.1 million in 2022, then dropped by 24.51% to -$1.1 billion in 2023, then decreased by 13.94% to -$1.3 billion in 2024, then decreased by 3.52% to -$1.3 billion in 2025.
  • Its Retained Earnings stands at -$1.3 billion for Q3 2025, versus -$1.4 billion for Q2 2025 and -$1.3 billion for Q1 2025.